In Brief: Genentech Nutropin AQ
Executive Summary
Genentech Nutropin AQ: Somatropin NDA 20-522/S-002 approved March 25 for treatment of growth failure associated with Turner Syndrome. Nutropin AQ is the liquid formulation of Nutropin (somatropin powder for reconstitution), which was approved for the Turner indication Dec. 30 ("The Pink Sheet" Jan. 6, T&G-3)...